🔎 Trials Near Me

Domov › Prekomerna telesna teža › Illinois › Chicago

Klinične študije za Prekomerna telesna teža v Chicago, IL

28 študij za Prekomerna telesna teža išče udeležence na lokacijah v Chicago in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 2
  • Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Vključevanje udeležencevFaza 2
  • Charter Research LLC - Chicago, Chicago
  • Flourish Research - Chicago, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Vključevanje udeležencevFaza 3
  • Great Lakes Clinical Trials, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Vključevanje udeležencevFaza 3
  • Chicago Research Center, Inc, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Vključevanje udeležencevFaza 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Cedar Crosse Research Center, Chicago
  • Northwestern University, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Rush University Medical Center, Chicago
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Vključevanje udeležencevFaza 3
  • Ann and Robert Lurie Children's Hospital of Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Vključevanje udeležencevFaza 3
  • Rush University Medical Center, Chicago
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Vključevanje udeležencevFaza 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Research Site, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Eagle Clinical Research, Chicago
  • University of Chicago, Chicago
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3
  • Chicago Research Center, Inc, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3
  • Flourish Research - Great Lakes Clinical Trials, Chicago
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

BRIDGE & Friends Trial

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • University of Illinois Chicago, Chicago
Starost 50–79 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07798557

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Illinois Institute of Technology, Chicago
Starost 21–74 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Vključevanje udeležencevFaza 3
  • ACCOMPLISH-1 Research Site, Chicago
Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Vključevanje udeležencev
  • Jesse Brown VA Medical Center, Chicago
Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Vključevanje udeležencevFaza 2
  • Mile Square Health Center Chicago, Chicago
  • Mile Square Health Center - Auburn Gresham, Chicago
  • Mile Square Health Center - Englewood, Chicago
  • in še 1
Vse starosti · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT07332741

Better Lifestyle Counseling for African American Women During Pregnancy

Vključevanje udeležencev
  • University of Illinois at Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Starost 18–40 · Ženske · Posodobljeno 9. jul. 2026 · NCT05234125

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Vključevanje udeležencevOpazovalna študija
  • Northwestern Memorial Hospital, Chicago
Starost 18–70 · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT07207148

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Vključevanje udeležencevFaza 3
  • University of Chicago, Chicago
Starost 18–75 · Vsi spoli · Posodobljeno 14. nov. 2025 · NCT06499857

Študije za Prekomerna telesna teža v drugih mestih

Druge študije v Chicago

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.